Literature DB >> 33508960

Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy.

Alessandro Rizzo1, Angela Dalia Ricci1, Giovanni Brandi1.   

Abstract

Entities:  

Keywords:  HCC; atezolizumab; bevacizumab; hepatocellular carcinoma; immune checkpoint inhibitors; immunotherapy

Year:  2021        PMID： 33508960     DOI： 10.2217/fon-2020-0986

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  26 in total

1.  Development of a Prognostic Nomogram in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Following Trans-Arterial Chemoembolization with Drug-Eluting Beads.

Authors:  Sihang Cheng; Xiang Yu; Siyun Liu; Zhengyu Jin; Huadan Xue; Zhiwei Wang; Ping Xie
Journal:  Cancer Manag Res       Date:  2021-12-24       Impact factor: 3.989

2.  Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study.

Authors:  Genghui Zhuang; Yuping Xie; Junfeng Hong; Shan Lin; Tingting Chen; Wenzheng Fang
Journal:  Infect Agent Cancer       Date:  2022-06-16       Impact factor: 3.698

3.  All-Trans-Retinoic Acid Plus Oxaliplatin/Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma with Pulmonary Metastasis: A Multicenter Retrospective Study.

Authors:  Juxian Sun; Chang Liu; Nanya Wang; Dafeng Jiang; Fan Zhang; Jie Shi; Shuqun Cheng
Journal:  Cancer Manag Res       Date:  2022-05-05       Impact factor: 3.602

4.  Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.

Authors:  Zeng-Hong Wu; Dong-Liang Yang; Liang Wang; Jia Liu
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

Review 5.  Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Alessandro Di Federico; Giorgio Frega; Andrea Palloni; Simona Tavolari; Giovanni Brandi
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

Review 6.  Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.

Authors:  Rui Xing; Jinping Gao; Qi Cui; Qian Wang
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

7.  Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.

Authors:  Zhihui Wang; Shuijun Zhang
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

8.  The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.

Authors:  Rixiong Wang; Nan Lin; Binbin Mao; Qing Wu
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-23       Impact factor: 4.322

Review 9.  An Overview of the Genomic Characterization of Hepatocellular Carcinoma.

Authors:  Sun Young Yim; Ju-Seog Lee
Journal:  J Hepatocell Carcinoma       Date:  2021-09-07

10.  An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma.

Authors:  Ying-Chun Shen; Pei-Chang Lee; Yi-Hsiang Huang; Ann-Lii Cheng; Yu-Lun Kuo; Wei-Kai Wu; Chieh-Chang Chen; Chengh-Hau Lei; Ching-Ping Yeh; Chiun Hsu; Chih-Hung Hsu; Zhong-Zhe Lin; Yu-Yun Shao; Li-Chun Lu; Tsung-Hao Liu; Chien-Hung Chen; Ming-Shiang Wu
Journal:  J Hepatocell Carcinoma       Date:  2021-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.